乐鱼（Leyu）体育官网 in Ukraine has advised Farmak JSC, a Ukrainian pharmaceutical company,鈥痮n financial and tax matters in connection with its investment in鈥疭ymphar, a Polish-based pharmaceutical marketing firm.
乐鱼（Leyu）体育官网 in Ukraine, with involvement of 乐鱼（Leyu）体育官网 Poland, performed financial and tax due diligence, analysed financial performance of the company, sustainability of EBITDA, working capital and net debt dynamics as well as significant areas of tax concern that should be addressed within the deal.
Acquisition of Symphar is a part of Farmak鈥檚 international expansion strategy to EU markets.
Finance: Svitlana Shcherbatyuk (Project leader), Hanna Butar, Oleksandr Ostrovskyi, Yaroslav Mykuliak
Tax (Poland): Ma艂gorzata Gle艅, Anna Kasprzyk, Mariusz Ruta, Agata G艂owacka, Oskar Kontny.
Tax (Ukraine): Oksana Olekhova,鈥�Mariia Klepakova
About Farmak
Farmak is an international pharmaceutical company, with manufacturing and R&D facilities in Ukraine and Spain, and more than 10 offices globally.
About Symphar
Symphar is a Warsaw-based pharmaceutical company, specializing in the diabetology, gynecology, psychiatry, neurology and other therapeutic areas.
